Chunlizhengda shareholders back key resolutions and dividend plan

Beijing Chunlizhengda Medical Instruments Co. Ltd. announced the successful passage of all proposed resolutions at its EGM and A Shareholders' Class Meeting held on November 19, 2025. Key special resolutions, including the abolishment of the supervisory committee and amendments to the articles of association, rules of procedures of the general meetings, and board meetings, each passed with over two-thirds of votes in favor. For instance, the abolishment of the supervisory committee received 95.3254% "for" votes at the EGM.

Ordinary resolutions also passed with significant majorities. Proposed amendments to the working system for independent directors and the management measures for use of proceeds both received over 93% "for" votes. Furthermore, the 2025 third quarterly profit distribution plan was approved with an overwhelming 99.9976% of votes in favor.

The board also declared a third quarter dividend of RMB2.10 per 10 shares (tax inclusive). For H shares, the dividend will be HK$0.23040 per share. The H Shareholders' Class Meeting has been adjourned to December 3, 2025, to finalize remaining approvals.